Rescue of Tumor-Infiltrating Lymphocytes from Activation-Induced Cell Death Enhances the Antitumor CTL Response in CD5-Deficient Mice
Open Access
- 1 July 2011
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 187 (1), 102-109
- https://doi.org/10.4049/jimmunol.1004145
Abstract
The CD5 coreceptor is expressed on all T cells and on the B1a B cell subset. It is associated with TCR and BCR, and modulates intracellular signals initiated by both Ag receptor complexes. Human CD5 contributes to regulation of the antitumor immune response and susceptibility of specific CTL to activation-induced cell death (AICD) triggered by the tumor. In this study, we compared the T cell response to the B16F10 melanoma engrafted into CD5-deficient and wild-type C57BL/6 mice. Compared with wild-type mice, CD5 knockout animals displayed delayed tumor growth, associated with tumor infiltration by T cell populations exhibiting a more activated phenotype and enhanced antitumor effector functions. However, control of tumor progression in CD5−/− mice was transient due to increased AICD of CD8+ tumor-infiltrating T lymphocytes. Remarkably, in vivo protection of T cells from TCR-mediated apoptosis by an adenovirus engineered to produce soluble Fas resulted in a dramatic reduction in tumor growth. Our data suggest that recruitment of tumor-specific T cells in the tumor microenvironment occurs at early stages of cancer development and that tumor-mediated AICD of tumor-infiltrating T lymphocytes is most likely involved in tumor escape from the immune system.This publication has 42 references indexed in Scilit:
- A Ligand for CD5 Is CD5The Journal of Immunology, 2010
- Inhibition of Superoxide Generation upon T-Cell Receptor Engagement Rescues Mart-127-35–Reactive T Cells from Activation-Induced Cell DeathCancer Research, 2009
- The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndromeProceedings of the National Academy of Sciences of the United States of America, 2009
- CD5 plays an inhibitory role in the suppressive function of murine CD4+ CD25+ Treg cellsImmunology Letters, 2008
- Expression of non-signaling membrane-anchored death receptors protects murine livers in different models of hepatitisHepatology, 2006
- FASL –844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancerThe Journal of Experimental Medicine, 2005
- The Accessory Molecules CD5 and CD6 Associate on the Membrane of Lymphoid T CellsPublished by Elsevier BV ,2003
- Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligandEuropean Journal of Immunology, 1999
- Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes.The Journal of Experimental Medicine, 1996
- Lymphocyte populations and immune responses in CD5‐deficient miceEuropean Journal of Immunology, 1994